CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY
Gardado en:
STOLTZ, J.A., ET AL., CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY. ADDICTION RESEARCH AND THEORY, Vol. 15, no. 1 (2007), p. 63-69.
Ref.
144458
Localización:
SIIS R.1038 Archivo
Palabras clave:
Características usuario, Drogas ilegales, Drogodependencias, Reducción de daños, Salas de venopunción, Vía intravenosa, EE.UU.
Características usuario, Drogas ilegales, Drogodependencias, Reducción de daños, Salas de venopunción, Vía intravenosa, EE.UU.
Títulos similares: CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY
- Injection drug use cessation and use of North America's first medically supervised safer injecting facility
- IDU perspectives on the design and operation of North America's first medically supervised injection facility
- Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study
- ATTENDANCE, DRUG USE PATTERNS, AND REFERRALS MADE FROM NORTH AMERICA'S FIRST SUPERVISED INJECTION FACILITY
- THE CANADIAN GOVERNMENT'S TREATMENT OF SCIENTIFIC PROCESS AND EVIDENCE: INSIDE THE EVALUATION OF NORTH AMERICA'S FIRST SUPERVISED INJECTING FACILITY
- SAFER INJECTION FACILITIES IN NORTH AMERICA: THEIR PLACE IN PUBLIC POLICY AND HEALTH INITIATIVES